Skip to content

Tacalcitol

DERMATOLOGICALS

ATC D05AX04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tacalcitol is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including VDR. Recorded indications include Plaque psoriasis.

  • Molecular targets: VDR (1 listed in DrugCentral).
  • Indications: Plaque psoriasis.
  • ATC code: D05AX04 (Other antipsoriatics for topical use).
  • Molecular formula: C27H44O3; molecular weight 416.65 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Plaque psoriasis

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Vitamin D3 receptorVDRagonistKd 8.50

ATC classification

ATC codeTherapeutic hierarchy
D05AX04DERMATOLOGICALS › ANTIPSORIATICS › ANTIPSORIATICS FOR TOPICAL USE › Other antipsoriatics for topical use

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tacalcitol is on its molecule page.

Molecular formulaC27H44O3
Molecular weight416.65 g/mol
CAS number57333-96-7
InChIKeyBJYLYJCXYAMOFT-RSFVBTMBSA-N
PubChem CID5283734
CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tacalcitol used for?

DrugCentral lists the following indications for Tacalcitol: Plaque psoriasis.

How does Tacalcitol work?

Its molecular targets in DrugCentral include VDR (agonist).

What is the chemical formula of Tacalcitol?

Tacalcitol has the molecular formula C27H44O3 and a molecular weight of 416.65 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC27H44O3
DrugCentral ID4727
Interactive profile